Mr. Cook has been a Board Member of Amylin Pharmaceuticals since 1994 and served as the CEO from 1998 through 2003. He will share his experience on how he managed and provided guidance on corporate governance while working for a company with a high level of uncertainty on the outcome. Amylin’s IPO was in 1992, delisted from Nasdaq in 1999 and now they have a market capitalization of over $5 billion. Join us for an exciting conversation with the 2006 Director of the Year Honoree for Enhancement of Economic Value!
LISTEN: SEGMENT ONE
Joe talks about how he managed corporate
governance at Amylin when there was a high level of uncertainty in regards
to the outcome in a turbulent environment
LISTEN: SEGMENT TWO
How does corporate govenance evolve as there
is a transition from high uncertainty to less uncertainty? Joe tells
us how he did this while still being focused on shareholder value.
LISTEN: SEGMENT THREE
Joe shares some of the
lessons learned and the principles of total governance, which means more
than just compliance with new rules.
